Current Executive Committee

DTAus Executive

Dr Chrys Pulle, MB BS FRACP (Chair)

Staff Specialist Geriatrician and Director Internal Medicine Dementia Research Unit at The Prince Charles Hospital, Metro North Hospital and Health Service, QLD Health.

Other appointments:

  •  Chair of Dementia Trials Australia 2019 – current.
  • President of the QLD Div ANZSGM  2017 – current.
  • Co chair Australasian Consortium of Centres for Clinical Cognitive Research 2016-2018.
  • Senior Lecturer, Northside Clinical School University of QLD
    President Qld Division of Australia New Zealand Society of Geriatric Medicine.
  • Chair Network of Fracture Education and Research, The Prince Charles Hospital.
Dr Karyn Boundy MBBS FRACP

Consultant Neurologist, SA.

Other appointments:

  • Dr Karyn Boundy has over 20 years experience in the area of cognitive neurology and formed the QEH memory Unit and Clinical trials Unit.
  • She is senior consultant neurologist who has worked within SA Health since 1992. Her special interests include multiple sclerosis , dementia and neurodegenerative disorders. She has extensive experience in dementia clinical trials and was Chair of AC4r for more than 10 years.
  • She worked at The Queen Elizabeth Hospital for many years and now, in addition to her private work at Western Neurology and Calvary Adelaide Hospital. She also is a consultant neurologist at the Cognitive Clinic at Flinders Medical Centre, and has set up the Cognitive Neurology Clinic there and runs the Huntington ‘s Disease Clinic. In addition to that she is a clinical lecturer of Adelaide University and does some teaching at Flinders University.
A/Professor Michael Woodward AM MB BS MD FRACP

Head of Aged Care Research and Memory Clinic, Austin Health, Heidelberg, VIC.

Other appointments:

  • Associate Professor Michael Woodward is Head of Aged Care Research and the Memory Clinic at Austin Health in Melbourne, Victoria, and an Honorary Medical advisor for Dementia Australia. He is a specialist in geriatric medicine with major interests in the treatment of Alzheimer’s disease (AD) and other dementias. He is Principal Investigator for numerous research trials of new therapies for AD and related disorders. He is Past President of the AC4R – the Australasian Consortium of Centres for Clinical Cognitive Research that brings together researchers into therapeutic agents for dementia. He was a member of the Alzheimer’s Australia Victoria Board, being appointed their chief medical advisor and chairing their research foundation, which administers over $2 million of research funding.
  • Michael Woodward’s publication record includes over 120 original research and review articles. He has been awarded his MD on the overlap between the dementia syndromes. More recent research interests have focussed on characterizing the frontal variant of Alzheimer’s Disease. He is a Fellow of the Australian Association of Gerontology (AAG), the Australian and New Zealand Society for Geriatric Medicine, the Australian Wound Management Association (AWMA) and the Royal Australasian College of Physicians (RACP) and has long served each of these professional bodies, including becoming President of AWMA and AAG (Vic) and chairing the Committee for Physician Training that oversaw the training of all RACP trainees.
A/Prof Kathryn Goozee

Director/CEO KaRa Institute of Neurological Diseases, and Director of Clinical Research and Dementia, Anglicare, (Sydney), NSW.

Other appointments:

  • Hon Associate Professor, Faculty of Medicine and Health Science, Macquarie University, NSW Adjunct Senior Lecturer, Edith Cowan University, WA
  • Associate Professor Kathryn Goozee is the Director and CEO of an independent Clinical Trials Centre and Memory Clinic in Macquarie Park, Sydney, NSW. She is an authorised Nurse Practitioner, specialising in dementia with a major interests in Alzheimer’s disease (AD). She provides clinical governance to a 20+ team of specialist clinicians, researchers, nurses and support staff to facilitate pharma clinical trials, across healthy, Mild Cognitive Impairment (MCI) and AD cohorts, and has earned a strong reputation for successful recruitment and quality output. A/Prof Goozee is also the Director of the Clinical Research Department (CRD), Anglicare and works in collaboration with Professor Ralph Martins and Macquarie University to support independent research in neuroscience.
  • Kathryn has authored over 20 original journal articles and written chapters in ‘Living with dementia: A practical guide for families and personal carers’ (2013), ‘Understanding Alzheimer’s’ (2013) and ‘Aged Care in Australia: A guide for aged care workers’ (2011). Within the community, she is a highly sought guest speaker, actively raising awareness of dementia prevention, detection, research and care. Prof Goozee is a member of Australian Association Gerontology (AAG); Dementia Australia; International Society to Advance Alzheimer’s Research and Treatment (ISTAART, USA); Australian College Nursing (ACN); and Australian College of Nurse Practitioners (ACNP).
Ms Roseanne Hogarth

Clinical Nurse Consultant and the Research Coordinator of the Curran Aging Research Unit at Hornsby Ku-ring-gai Hospital, NSW.

Other appointments:

  • Roseanne Hogarth is a Clinical Nurse Consultant and the Research Coordinator of the Curran Aging Research Unit at Hornsby Ku-ring-gai Hospital, she has held this position since 2000. Roseanne is co-author of the medical text Physical Comorbidities of Dementia and the Consumer Edition she holds a Masters in Health Informatics; her special interests are consumer education on dementia prevention, management and cognitive research.
Dr Roger M Clarnette, MB BS PhD FRACP

Geriatrician in the Department of Community and Geriatric Medicine, Fremantle Hospital and Health Service, WA.

Other appointments:

  • Medical Director, Australian Alzheimer’s Research Foundation.
  • Clinical Associate Professor, Medical School, University of Western Australia.
  • Senior Sessional Member, State Administrative Tribunal, WA.
  • Deputy Head of Department, Geriatric Medicine, Fiona Stanley Fremantle Hospitals Group, Western Australia.

Medical Director for Gold Coast Memory Disorders Clinic, QLD.

Other appointments:

  • Dr Morris has medical qualifications MBBS (Hons), BSc(med) (Hons), and PhD. He is qualified in general adult psychiatry, psychiatry of older age, forensic psychiatry and addiction medicine in Australia and is a Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP) and a Fellow of the Australian Chapter of Addiction Medicine (FAChAM) of the Royal Australasian College of Physicians. He is qualified in general adult psychiatry and geriatric psychiatry in the USA and is Board Certified by the American Board of Psychiatry and Neurology (ABPN). He has been a Certified Independent Medical Examiner of the American Board of Independent Medical Examiners (ABIME). Dr Morris is President of the Australian and New Zealand Mental Health Association.
  • He has a private psychiatric practice and memory clinic on the Gold Coast. He is a member of the Department of Vererans’ Affairs Repatriation Pharmaceutical Reference Committee. Dr Morris is a visiting professor at the Bond University Medical School. He has held professor positions in psychiatry at the University of Melbourne and the University of Queensland. Dr Morris was Foundation Professor/Director of the National Centre for War-related Post Traumatic Stress Disorder in Melbourne. His clinical and research interests include neuropsychiatry, memory disorders, psycho geriatrics, post-trauma syndromes, clinical drug trials and co morbid drug and alcohol and psychiatric conditions.
Dr Cathy Short BSc, MBBS, FRACP

Clinical Lead- Central Adelaide Local Health Network Memory Service and Memory Clinical Trials, SA. 

Other appointments:

  • Dr Short graduated from the University of Adelaide Medical School in 1995 and received her FRACP in Neurology and General Medicine in 2003. She is currently a Consultant Neurologist for the Central Adelaide Local Health Network (CALHN) which encompasses both The Royal Adelaide and Queen Elizabeth Hospitals in South Australia. She is the Clinical lead for the multi-disciplinary CALHN Memory Service and Head of CALHN Memory Trials which runs across both hospital sites.
  • She has a special interest in Behavioural Neurology and the Dementias as a group of disorders. She has been working as a Neurology Staff Specialist for 17 years and has been actively involved in more than 60 Clinical drug trials for Alzheimer’s disease and other dementias over that time.
Professor Christopher Rowe BMBS, FRACP, MD, FAANMS

Director of Molecular Imaging Research at Austin Health and the University of Melbourne, VIC.

Other appointments:

  • Christopher Rowe is a nuclear medicine physician and neurologist, with over 20 years of experience in dementia research and patient care.
  • He is the Principle investigator and Director of the Australian Dementia Network (ADNeT) established across the nation in late 2018 with funding from the Federal Government through the NHMRC National Institute of Dementia Research and philanthropic donors. His research focus is molecular brain imaging of neurodegenerative diseases, particularly Alzheimer’s disease, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions.
  • He is a 2019 Highly Cited Researcher (top 1% world-wide for neuroscience) and has received international awards for his work including the US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the Christopher Clark Award for advancing human amyloid imaging.
Dr Tina Soulis PhD, BSc

Chief Executive Officer at Neuroscience Trials Australia & Clinical Development Specialist, VIC.

Other appointments:

  • Tina is considered an industry thought leader and Australian international advocate for clinical trials. She contributes to and is a pivotal member on many Australian and international clinical trial advocacy, policy and neurology focused leadership groups.
  • Over the past 7 years, Tina has built up Neuroscience Trials Australia, a leading global specialised brand making Australia a destination for many overseas companies wanting to undertake neurology focused clinical research. This Contract Research Organisation (CRO) is globally unique and offers clients access to clinical trial sites, expertise and capabilities required to complete clinical development at global standard.
  • Prior to her role with Neuroscience Trials Australia, Tina was the director of clinical development at Acrux Pharma Pty Ltd, a successful Australian ASX200 biotechnology company. Tina led the strategic direction, development, co-ordination and reporting of the company’s clinical programs. Tina had pivotal involvement in taking a product (Axiron), right through all stages of clinical development and in submission of the product dossier for US regulatory approval and subsequent out licensing of the product to one of the world’s largest pharmaceutical companies.
  • Tina is an expert driver of clinical drug development, particularly in the design, management and implementation of clinical trials and has worked as a clinical researcher and in senior roles within the pharmaceutical and biotechnology industry for over 25 years. Her experience encompasses all stages of drug and device development in many therapeutic areas and geographical regions.

Nominated Centres:

  • Austin Hospital – VIC
  • Caulfield Hospital (Alfred) – VIC
  • Concord Hospital – NSW
  • Dementia Collaborative Research Centre – NSW
  • Hornsby Ku-ring-Gai – NSW
  • KaRa Institute of Neurological Diseases, Sydney – NSW

  • Neuroscience Research Australia – NSW
  • Southern Neurology – NSW

  • PL Morris – QLD
  • The Prince Charles Hospital – QLD
  • Flinders Medical Centre – SA
  • Royal Adelaide Hospital – SA
  • Queen Elizabeth Hospital – SA
  • Australian Alzheimer’s Research Foundation – WA
  • Neurodegenerative Disorders Research Pty Ltd – WA
  • Optimal Clinical Trials – NZ